Ephedra Ban Court Challenge Could Be Good News For FDA, Win Or Lose
This article was originally published in The Tan Sheet
Executive Summary
FDA's decision to ban ephedra outright creates a win-win situation for the agency, regardless of whether the regulation stands up in court